ClawBio is an open-source, AI agent skill library specifically designed for bioinformatics, officially released by the ClawBio Team in June 2026. Built upon the widely validated OpenClaw architecture within the developer ecosystem, this tool provides standardized specifications to enable agents to perform complex and fragmented computer biology analysis processes safely and consistently, overcoming the high barrier to entry. Biological researchers can immediately begin genomics, pharmacogenomics, and spatial transcriptomics research by simply executing a single command in the terminal environment or making a simple library call, without having to deal with the complex package dependency issues of programming languages. Just as an operating system (OS) uses standardized device drivers as an intermediary to control various hardware, ClawBio acts as an intermediary layer, helping large language model agents communicate safely with heterogeneous bioinformatics command-line tools and web databases. Traditional AI-based analysis methods followed an impromptu and stochastic approach, where agents would write and execute arbitrary Python code based on the researcher's natural language requirements. However, this approach carries a high risk of making critical errors in genomic analysis. For example, the agent may fail to reflect the latest clinical guidelines or confuse the genetic classification of Star Alleles, leading to incorrect judgments of drug warning levels. When administering anticancer drugs such as fluorouracil, overlooking specific gene mutations can cause fatal toxicity in patients, so strict constraints on the agent's autonomous code generation are essential. Instead of giving the agent a high degree of freedom in prompting, ClawBio enforces a pre-verified, specific skill specification (SKILL.md) by domain experts as a condition of the execution contract. This fundamentally prevents the hallucination phenomenon of language models and consistently ensures the statistical precision and scientific safety of the analysis results. In real-world biotechnology research, ClawBio helps efficiently design high-load pipelines, ranging from personalized precision medicine analysis to large-scale population genetics analysis. When a researcher uploads a patient's raw variant data (VCF) file and a photo of the drug packaging taken with a smartphone, the agent identifies the drug's ingredients in the local environment and compares them with the Clinical Pharmacogenetics Implementation Consortium (CPIC) database to issue an optimal dosage card in real-time. Furthermore, by utilizing the polygenic risk score calculation skill, it can comprehensively analyze thousands of minor variant effects to predict genetic susceptibility to specific diseases, and all of this process is handled in a local-first manner, ensuring that sensitive information is not transmitted to external servers. After the analysis is complete, the commands.sh (reproducible commands) and environment.yml (metadata for reconstructing the same package environment) are recorded in the results directory along with checksum information, making it easy to achieve smooth cross-validation and a high level of reproducibility among fellow researchers.

ClawBio is an open-source, AI-powered agent skill library specifically designed for bioinformatics, officially released by the ClawBio Team in June 2026. This tool is built upon the OpenClaw architecture, which has been widely validated within the developer ecosystem. It provides standardized specifications to enable agents to perform complex and fragmented computer biology analysis processes safely and consistently, thereby lowering the barrier to entry. Biological researchers can use it in a terminal environment with a single command, without having to deal with the complex package dependency issues of programming languages.

🔬 Generate Personalized Medication Prescription and Dosage Guidelines: Combine patient VCF genomic data and smartphone-captured medication packaging images to identify star alleles such as CYP2D6 and DPYD, and generate a personalized dosage card that aligns with CPIC guidelines, preventing genetic adverse effects and enabling precision medicine.